Vistin Pharma ASA
OSE:VISTN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vistin Pharma ASA
OSE:VISTN
|
NO |
|
T
|
Teamway International Group Holdings Ltd
HKEX:1239
|
HK |
|
O
|
Oriola Oyj
OMXH:OKDBV
|
FI |
|
Lululemon Athletica Inc
NASDAQ:LULU
|
CA |
|
G
|
Gungnir Resources Inc
OTC:ASWRF
|
CA |
|
Niitaka Co Ltd
TSE:4465
|
JP |
|
Poojawestern Metaliks Ltd
BSE:540727
|
IN |
|
Geostr Corp
TSE:5282
|
JP |
|
Shree Digvijay Cement Co Ltd
NSE:SHREDIGCEM
|
IN |
|
G
|
Gremi Media SA
WSE:GME
|
PL |
|
F
|
Foundpac Group Bhd
KLSE:FPGROUP
|
MY |
|
S
|
Suncare Traders Ltd
BSE:539526
|
IN |
|
Fortum Oyj
OTC:FOJCY
|
FI |
|
D
|
Dhanvantri Jeevan Rekha Ltd
BSE:531043
|
IN |
|
Unibel SA
PAR:UNBL
|
FR |
|
L
|
Luks Group (Vietnam Holdings) Company Ltd
HKEX:366
|
HK |
|
Management Solutions Co Ltd
TSE:7033
|
JP |
|
Computer Engineering & Consulting Ltd
TSE:9692
|
JP |
|
Z
|
Zhejiang Heda Technology Co Ltd
SSE:688296
|
CN |
Vistin Pharma ASA
Vistin Pharma ASA engages in the manufacture and sale of metformin products. The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The company was created as a result of spin-off of Weifa AS. The company specializes in manufacture of Active Pharmaceutical Ingredients (API) and Solid Dosage Forms. Its products portfolio is comprised of Metformin, Pholcodine and Codeine Phosphate, among others. The firm's products are sold domestically and abroad, including markets in Asia, America, Africa and Europe.
Vistin Pharma ASA engages in the manufacture and sale of metformin products. The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The company was created as a result of spin-off of Weifa AS. The company specializes in manufacture of Active Pharmaceutical Ingredients (API) and Solid Dosage Forms. Its products portfolio is comprised of Metformin, Pholcodine and Codeine Phosphate, among others. The firm's products are sold domestically and abroad, including markets in Asia, America, Africa and Europe.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
